Immunology articles for Netherlands

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 75

Article ‘Count’ for Immunology.

Journal Count Share
1 0.70
Quantum sensing to monitor changes in free radical generation by intracellular vesicles of polarized macrophages 0.70
1 0.10
Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy 0.10
2 0.53
Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury 0.50
ARDS Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes. 0.03
1 0.03
Decoding a Gut Commensal Signal: Structural and Immunological Profiling of Segatella Copri Lipopolysaccharide 0.03
2 2.00
Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis 1.00
Dimerization as a key feature of autoreactive IgA antibody responses 1.00
1 0.01
Comparative efficacy and safety of anakinra and canakinumab in patients with scpVEXAS/scp syndrome – an international multicenter study 0.01
4 1.19
DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival 0.08
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis 0.17
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy 0.89
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study 0.06
2 1.08
Subclonal immune evasion in non-small cell lung cancer 0.08
Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread 1.00
1 0.05
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Co-evolution in Pancreatic Cancer. 0.05
1 0.09
Myosin II regulates cellular thermo-adaptability and the efficiency of immune responses 0.09
2 0.10
HIF-1α+ CD4+ T cells coordinate a tissue-resident immune cell network in the lung 0.02
Antibody-mediated feedback modulates interclonal competition in the germinal center 0.08
1 0.03
Precision Immunotherapy to Improve Sepsis Outcomes 0.03
2 0.13
Identification and characterization of nanobodies specific for the human ubiquitin–like ISG15 protein 0.07
Molecular basis for presentation of N-myristoylated peptides by the chicken YF1*7.1 molecule 0.07
2 0.99
uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells 0.05
Galectin-9 regulates dendritic cell polarity and uropod contraction by modulating RhoA activity 0.95
1 0.13
CD38 expression by neonatal human naïve CD4+ T cells shapes their distinct metabolic and tolerogenic properties 0.13
4 0.20
A circadian checkpoint relocates neutrophils to minimize injury 0.13
Genetically heterozygous - transcriptionally homozygous IRF7 deficiency underlies herpesvirus CNS infections in humans 0.04
ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma 0.01
Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency 0.02
1 0.01
Molecular signatures discriminating different types of rejection in human liver transplants 0.01
1 0.07
A Functional Polymorphism in IL-36β Modulates Macrophage Antifungal Effector Functions and Increases Susceptibility to Invasive Pulmonary Aspergillosis 0.07
1 0.23
Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity 0.23
1 0.07
Cerebellar microglia-derived IL-17A mitigates autism-related behavioral and synaptic deficits 0.07
2 0.87
Human gut M cells resemble dendritic cells and present gluten antigen 0.84
Erythropoietin receptor on cDC1s dictates immune tolerance 0.03
11 5.11
Molecular signatures and causal factors underlying latent cytomegalovirus infection among people living with HIV (PLHIV) 0.63
Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model 1.00
Structural insights into C3 convertase activity of the classical pathway of complement 1.00
Double stranded RNA sensing is silenced during early embryonic development 0.23
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.01
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection 0.10
Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses 0.86
Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models 0.15
Artificial Intelligence (AI)-assisted readout method for the evaluation of skin prick automated test results 0.05
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart 0.07
Intestinal tuft cell subtypes represent successive stages of maturation driven by crypt-villus signaling gradients 1.00
1 0.02
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1 macrophages 0.02
4 0.17
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID 0.04
Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity 0.06
The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells 0.02
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor 0.05
2 0.20
Interpretable inflammation landscape of circulating immune cells 0.13
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma 0.07
1 0.63
Synthesis of Adenosine Diphosphate Ribose Histidine 0.63
1 0.27
Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response 0.27
1 0.04
Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study. 0.04
2 1.02
The intestinal microbiota impacts nutritional immunity and resistance to Acinetobacter baumannii pneumonia 0.02
Melanocyte-dependent macrophage redistribution enhances skin immunity upon acute stress 1.00
5 1.58
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire 0.13
Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling 0.07
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells 1.00
Antigen-specific B cell response regulation by IL-10–producing tolerogenic dendritic cells 0.36
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality 0.02
2 0.83
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114 0.63
Tissue-resident memory CD4+ T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice 0.20
2 1.33
Single-molecule imaging of transcription dynamics, RNA localization and fate in human T cells. 1.00
The twist-and-squeeze activation of CARF-fused adenosine deaminase by cyclic oligoadenylates 0.33
5 1.40
Epidemiology and Management of Malignancies in Patients with Inborn Errors of Immunity - An ESID Registry Study of 19,959 Patients 0.09
Immunological biomarkers of non-infectious complications and overall survival in common variable immunodeficiency 0.01
Late Effects After Haematopoietic Stem Cell Transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP and TCWP EBMT Study 0.03
Genetic Determinants of the Complement and Coagulation Pathways in Invasive Meningococcal Disease 0.27
Long-term prophylactic treatment with deucrictibant for angioedema due to acquired C1-inhibitor deficiency 1.00
3 0.19
Ianalumab plus Eltrombopag in Immune Thrombocytopenia 0.04
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.03
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia 0.12
1 0.08
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.08

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.